Gunderson Dettmer represented client Orange Health, a Bengaluru-based health-tech startup, in its $25 million Series B financing led by Bertelsmann India Investments and General Catalyst, with participation from Accel, Y Combinator, Good Capital and Uncorrelated Ventures. The company plans to use the new capital for product development, technology, building laboratories, as well as expansion into new markets.

In the announcement of the transaction, co-founders at Orange Health Dhruv Gupta and Tarun Bhambra said, “While traditional diagnostic labs need patients to come to them at collection centers, most home collection diagnostic companies haven’t been able to reliably provide services in a timely manner. Orange Health’s affordable, on-demand service addresses this market gap. As a tech-enabled diagnostics company built around the customers, our focus has always been on speed and reliability. Because every caregiver innately knows that adopting urgency is the best way to show care in healthcare.”

The Gunderson deal team was led by Jonathan Pentzien and included Benjamin Teo, Binh Vong, Jonathan Beh and Lim Jun Heng.

Companies:
Orange Health
Bertelsmann India Investments
General Catalyst